-
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, 1 Dec 2023, In: The Lancet Diabetes and Endocrinology. 11, 12, p. 905-914Research output: Contribution to journal › Article › Academic › peer-review
-
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, 6 May 2023, In: The Lancet. 401, 10387, p. 1499-1507 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Improving empirical antibiotic treatment: The role of diagnostic accuracy and surveillance
Ginting, F., 2023, 253 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
- All publications